OBJECTIVE: To test whether implementing a nursing-driven comfort protocol standardizes morphine use in one neonatal intensive care unit (NICU) and to examine how non-standard morphine (N-SM) relates to days of ventilation, days of total parenteral nutrition (TPN) and length of stay (LOS). STUDY DESIGN: This was a retrospective/prospective observational study using pharmacy records, medical records, and an outcomes database. Comfort protocol implementation began February 2011 and was applied to preterm, ventilated neonates o 1500 grams. Pre-and post-implementation proportions of N-SM days were compared using the binomial test. A percent 'P'-chart spanning 30 quarters was constructed with statistical-process control analysis. Multivariable linear regression adjusting for acuity assessed the relationship between N-SM use and days of ventilation, TPN and LOS. RESULT: Hundred and thirty-four patients met inclusion criteria, 116 prior to and 18 after implementation. The proportion of patients given N-SM for one or more days decreased from 59 to 35% after protocol implementation (P = 0.017). A 9-month period of decreased N-SM days was observed after protocol implementation. Controlling for acuity, each additional day of N-SM use was associated with 0.47 more days of ventilation (95% confidence interval (CI): 0.26-0.69, P o 0.001) and 0.52 more days of TPN (95% CI: 0.35-0.68, P o 0.001). Exposure to N-SM was associated with 17 additional days of hospitalization (P = 0.009, 95% CI: 4.5-30). CONCLUSION: Implementing a nursing-driven comfort protocol significantly reduced N-SM use. N-SM in the NICU is negatively associated with key clinical outcomes. Testing similar protocols in other settings is warranted.
INTRODUCTION
Over the past 30 years, neonatologists have shifted from debating whether or not neonates feel pain 1, 2 to debating how best to ameliorate it. 2 A large amount of this work, including creation and widespread implementation of behavioral indicators to assess pain 3, 4 and a focus on both pharmacologic and non-pharmacologic 5, 6 interventions to alleviate pain, is centered around acute, procedural pain. Providing analgesia, either with developmental comfort measures, 6 sucrose, 5 or narcotics such as morphine, is the current standard of care in the neonatal intensive care unit (NICU). We define standard morphine use as morphine given for analgesia for ongoing painful stimuli.
Administering morphine to neonates as a sedative during invasive mechanical ventilation is not recommended. 7, 8 Studies show no benefit and potential harm. 7 A one-size-fits-all approach to managing neonates on ventilators, otherwise known as preemptive analgesia, does not improve hospital-based outcomes in blinded, randomized controlled trials in the preterm population. 9, 10 The neonatal pain control group, a group established by the FDA (Food and Drug Administration) and the NIH (National Institutes of Health) in 2003, published evidence-based recommendations for care of critically ill, preterm patients in 2004 discouraging use of empiric sedation for neonates receiving mechanical ventilation. 8 Long-term follow-up studies of morphine given for preemptive analgesia are underpowered to accurately assess morphine's impact on neurodevelopmental outcomes 11, 12 but there are concerns based largely on animal data. 13 We therefore define non-standard morphine (N-SM) use as morphine given for preemptive analgesia or morphine used without ongoing, patient-specific measures of pain.
The context in which care is provided is in large part responsible for the gaps in knowledge translation surrounding pain management guidelines in the NICU. 14, 15 Navigating professional hierarchies, particularly in the absence of unit-wide standards, results in inconsistent and delayed analgesia at the bedside. 15 It is unknown whether using nursing-driven protocols to curtail professional hierarchies will allow for standardized pain management and positively impact outcomes for ventilated preterm neonates. Synthesizing adult 16 and pediatric 17 ICU literature with the pharmacology literature for neonatal sedation 18 formed the foundation for a new, nursing-driven comfort protocol in our NICU. In this study we aimed to examine (1) whether implementing a nursing-driven comfort protocol in our NICU standardized morphine use; and (2) the relationship between clinical outcomes and N-SM use.
METHODS Definitions
Standard continuous morphine infusion use was defined as treatment of a known source of pain (for example, an indwelling chest tube), used in the context of neonatal abstinence syndrome, used during laser eye surgery, used to facilitate synchronous ventilation in patients with profound, refractory hypoxemia or hypercarbia or palliative care. After introduction of our protocol, standard use also included use as prescribed by the protocol. N-SM was defined as continuous morphine infusion used for empiric sedation during conventional or high-frequency ventilation (HFOV); 1 agitation without ongoing, rigorous patient-centered assessments of agitation throughout the duration of infusion; or extending use more than 72 h after surgical ligation of a patent ductus arteriosus (PDA).
Study design
We conducted a retrospective/prospective review of morphine use in ventilated preterm neonates at the University of Washington Medical Center NICU between June 2005 and August 2012. A new comfort protocol was introduced in February 2011 and was deemed fully implemented by 1 August 2011. Full implementation meant that all nurses working in the NICU were oriented to the protocol, educational materials for the protocol were available, order sets were written and approved by the hospital order set committee and by the NICU medical director and nursing leadership counsel, and on-site residents and fellows were introduced to the protocol. Since introduction of the protocol to faculty in February 2011 altered clinical practice, causing fewer patients on HFOV to receive N-SM, we define our pre-implementation period from1 June 2005 through 31 January 2011 and our post-implementation period from 1 February 2011 through 30 August 2012. Data collection occurred for 12 months after full implementation. All patients born on or after 1 February 2011 were analyzed in the post-implementation group.
The NICU is an academic, 36-bed level III unit that expanded to 48 beds in October 2012 with an average of 400 admissions annually. Patients are primarily inborn. The only surgeries (with few exceptions) provided at our center are PDA ligation and laser eye surgery for retinopathy of prematurity. The scope of this study was to examine use of continuous morphine infusions; we did not include morphine boluses as they were rarely given for indications other than an acute, painful procedure. Developmental comfort measures are the default mode of care in our NICU for management of acute and chronic pain. Acetaminophen is prescribed orally only after routine immunizations. With very rare exception, we do not use fentanyl or benzodiazepine 19 infusions in our NICU.
Study sample
Inclusion criteria were patients admitted to the NICU within the time of review who were ⩽ 1500 g at birth and ventilated with conventional or Figure 1 . Comfort protocol.
Standardizing morphine use for preterm neonates R Fleishman et al high-frequency mechanical ventilation. Patients were excluded if they weighed 41500 g at birth, were never ventilated or were transferred out for acute care (for example, general surgical consultation). We also excluded all patients who died within the first week of life as their acuity and clinical outcomes are quite different from the remainder of the eligible cohort.
Data collection
With approval from the University of Washington Institutional Review Board, we used pharmacy records and an existing database tracking patient outcomes and patient demographics to generate data for this study. The database provided patient diagnoses such as necrotizing enterocolitis and late-onset sepsis, the duration of ventilation and the need for surgery. We obtained days of morphine infusion and total parenteral nutrition (TPN) from pharmacy reports and manual chart review. Chart reviews, done by a single physician reviewer (RF), focused on documented indications for prescribing morphine infusions. The indication for morphine was assigned based on the clearest rationale charted. If multiple indications were noted-for example, a patient with chest tubes on HFOV-the patient was classified as receiving standard morphine. If no rationale was noted, the indication was classified as 'unclear' and this was considered standard for the purposes of analysis. Two neonatologists (RF and CG) defined morphine indications as standard or N-SM prior to chart review.
Pre-protocol baseline
Extensive chart review prior to protocol implementation revealed that the most frequent reasons for N-SM were (1) empiric use during HFOV and (2) extending use 472 h after a PDA ligation. Our protocol and nursing education therefore focused specifically, but not exclusively, on these conditions. One of the changes implemented with the protocol was to start actively using the Behavioral Indicators of Infant Pain 20 to make decisions about morphine. While this metric was always documented, it was only with protocol implementation that these scores became clinically meaningful.
Protocol development
We developed our own comfort protocol as no published nursing-driven protocols for managing ventilated preterm neonates existed at the time we began this study (Figure 1) . The nursing-driven comfort protocol we developed was modeled after published guidelines used in adult and pediatric ICUs. 21, 22 A multi-disciplinary team including neonatal faculty, pharmacy and nursing leadership met to inform development of the protocol. All staff including nurses, attending neonatologists, nurse practitioners, pharmacists and residents received orientation to the protocol.
The morphine doses we chose were based on literature describing morphine pharmacokinetics in the preterm neonatal population and on personal communication with Dr van den Anker regarding his clinical trial (www.clinicaltrials.gov/ct2/show/NCT00494429). Indications for bolus doses of morphine or titration of morphine infusion were based on the Behavioral Indicators of Infant Pain score 20 obtained at the bedside prior to initiation of patient care. The bedside nurse could administer a morphine bolus or titrate the morphine infusion based on the pain score at the point of care. The protocol recommended routine decreases of infusion rate every 12 h in the absence of high pain scores or bolus doses of medication.
Data analysis
We compared pre-to post-implementation N-SM use by applying the twosample test of proportions. Student's t-test was used to compare outcomes across the two groups. We plotted a percent statistical-process control chart (P-Chart) showing percent of all morphine days per patient judged to be N-SM use over 30 quarters (23 pre-and 7 post-implementation) to demonstrate N-SM use over time. We applied multivariable linear regression model to compare percent of N-SM days per patient pre-and post-protocol, controlling for acuity and days of HFOV.
We used multivariable linear regression adjusting for acuity to assess the relationship between N-SM use and days of ventilation, days of TPN and LOS. Two measures of N-SM use were considered in the analysis: number of days a patient received N-SM and a binary indicator of any N-SM use while ventilated (at any time). The variables used to define acuity were selected a priori based on two neonatologist's impression of diagnoses that indicate more acute clinical course and included: small for gestational age, birth weight, need for laser eye surgery for retinopathy of prematurity, having a PDA ligation, Bell's Stage IIa or IIb necrotizing enterocolitis, late-onset sepsis and discharge home on oxygen. Stages IIIa and IIIb necrotizing enterocolitis were not included because those patients were transferred for pediatric surgical consultation and were excluded from our study. Retinopathies of prematurity surgery and PDA ligation were chosen as proxy markers for the acuity that lead to the need for surgery, not because the procedures in and of themselves were painful. Statistical analysis was done using STATA SE 12.0 (College Station, TX, USA). A P-value ofo 0.05 was considered significant.
RESULTS

Standardization of morphine use
There were 116 patients in the pre-implementation period and 18 patients in the post-implementation period (Figure 2 ). The three patients in the final quarter of protocol implementation who received N-SM are included in the 18 post-implementation group. The proportion of patients given morphine judged to be N-SM for Standardizing morphine use for preterm neonates one or more days decreased from 59% (95% confidence interval (CI): 50-68%) to 35% (95% CI: 17-51%) after comfort protocol implementation (P = 0.017). The mean number of N-SM days per patient trended downward, from 9.5 to 5.0 days in the post-intervention period (P = 0.073). The mean number of days on HFOV without morphine infusion increased from 1 to 3.7 days after the intervention (P o0.001).
A statistical-process control P-chart demonstrates a 9-month period of decreased N-SM use after protocol implementation ( Figure 3) followed by a 2-month period where three out of the three patients given morphine infusions were given N-SM. Controlling for acuity, there was a 30% (95% CI: 6.3-53%, s.e. (standard error): 11; P = 0.013) decrease in the percent of all morphine use judged to be N-SM.
Outcomes analysis
There were 134 patients who met inclusion criteria at any time during the study (Figure 2 ). Baseline characteristics between those given standard morphine and those given morphine judged to be N-SM were not significantly different, with the only exception being death (Table 1) . We believe this discrepancy is owing to our definition of standard morphine, which included morphine given for palliative care within 24 h prior to compassionate extubation.
After controlling for acuity, each additional day of N-SM use was found to be associated with 0.47 more days of ventilation (95% CI: 0.26-0.69, s.e.: 0.11; P o 0.001) and 0.52 additional days of TPN (95% CI: 0.35-0.68, s.e.: 0.08; P o 0.001). Exposure to N-SM was also associated with 17 additional days of hospitalization (95% CI: 4.5-30, s.e.: 6.5; P o 0.01). In contrast, days of standard morphine use were not significantly associated with increased ventilation days, TPN days or length of stay.
DISCUSSION
We found that development and implementation of a nursingdriven, patient-targeted comfort protocol decreased N-SM use in our NICU. The proportion of patients given any morphine judged to be N-SM decreased, as did the percentage of N-SM days used per patient. We also observed a decrease in the amount of morphine given empirically for HFOV after protocol implementation despite difficulty in sustaining protocol use over time (Figure 3 ).
Sustaining change in any care setting, including the NICU, is complex. 23 The Vermont Oxford Network has had great success with their collaborative groups in implementing and sustaining evidence-based initiatives to target specific neonatal conditions. 24 Multidisciplinary teams that frequently reassess the efforts of their initiatives are the key to sustain evidence-based changes. 25 We believe our inability to sustain changes related to NS-M use were related to (1) a lack of ongoing multidisciplinary investment in our protocol, partially owing to changes in nursing leadership after implementation, and (2) a shift from paper orders, around which the protocol was designed and fastidious attention paid to nurse usability, to computerized provider order entry, where the protocol was hard-wired but not as useable for the bedside nurse.
N-SM was also found to be associated with prolonged days of ventilation, TPN use and length of stay. While our analyses do not establish causal relationships between morphine use judged to be N-SM and these outcomes, data from prospective, randomized controlled trials 9,10 do link pre-emptive analgesia (which we classify as non-standard) with more time to reach full enteral feeds 26 and more bronchopulmonary dysplasia. 27 Preemptively providing analgesia with continuous morphine is additionally linked to increased rates of IVH, more episodes of hypotension and increased tone at 36 weeks. 10, 26, 28, 29 The unit specific protocol we developed and implemented translated this evidence into practice. However, the post-implementation cohort of eligible neonates in the current study was not large enough to demonstrate that standardizing morphine use was associated with improvement in outcomes. We believe that a future multi-site prospective study with a more robust sample of patients in the post-protocol implementation time period may demonstrate decreased numbers of ventilator, TPN and hospital days. Standardizing morphine use for preterm neonates R Fleishman et al Clinical practice guidelines for sedation of adult ICU patients cite category A evidence recommending nursing-driven, patienttargeted, protocolized sedation as the gold standard in providing patient comfort and improving outcomes such as length of ventilation, length of ICU stay, delirium and post-traumatic stress disorder. 16 The RESTORE study, 17 currently underway, aims to bring pediatric ICUs in line with adult ICU standards. We believe this same strategy is appropriate in the NICU setting.
A nursing-driven comfort protocol, by design, creates a culture of collaboration and facilitates autonomous decision-making by undoing the professional hierarchy that is known to provide a barrier to adequate pain management in the NICU. 15 Many patients in the NICU still experience painful procedures without any analgesia, 30 regardless of the impacts on short-and long-term outcomes. 31 A protocol like ours provides a systematic, evidencebased method to assess and treat both acute and chronic pain. Our outcomes analysis indicates that a nursing-driven comfort protocol should improve patient outcomes.
We conclude that nursing-driven comfort protocols are feasible in the NICU and have the potential to positively impact patient outcomes. This study offers one institution's approach to managing the comfort care of preterm neonates receiving mechanical ventilation. A multi-center trial in which different NICUs are randomized to protocolized sedation versus routine care is the next step in understanding if the approach of adult and pediatric intensivists generalizes to neonatal patients. Long-term follow-up studies assessing the outcomes of this type of intervention will be critical for the better understanding of the impacts of N-SM use versus patient-targeted analgesia on the developing neonatal brain.
Limitations
These data pertain to one NICU and may not generalize to other NICUs. Despite the single-site design, the sedation practices in use prior to protocol implementation are likely not unique to our institution. The limited sample size in the post-implementation period did not allow evaluation of the protocol's potential association with improved clinical outcomes. Some data were collected from internal databases that may contain data entry errors. Indications for prescribing morphine infusion were determined from medical record review and the records may not adequately reflect decisions made at the bedside. The use of some morphine deemed nonstandard might thus have been standard, and vice versa. Abbreviation: OR, odds ratio. a N = 20 given standard morphine and 55 given non-standard morphine.
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